New RejuvenNOX
Natural health product licensed in Canada
- Other names
- RejuvenNOX
- Licence holder
- Advanced Orthomolecular Research Inc.
- NPN or DIN-HM
- 80087327
- Status
- Active licence
- Licence date
- 23 July 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Beta vulgaris Source : Racine Extract : Matériel brut sec Extraction ratio : 548.588:1 Dry plant equivalent : 318 Grammes Potency : 272.33 milligramme Betaine | 579.67 milligramme | Not calculated |
| Withania somnifera Source : Racine Extract : Matériel brut sec Extraction ratio : 9.96:1 Dry plant equivalent : 830 milligramme Potency : 2 % Withaferin A | 83.33 milligramme | Not calculated |
| Withania somnifera Source : Feuille Extract : Matériel brut sec Extraction ratio : 9.96:1 Dry plant equivalent : 830 milligramme Potency : 2 % Withaferin A | 83.33 milligramme | Not calculated |
| Camellia sinensis Source : Feuille Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 1,000 milligramme Potency : 1 % Caffeine | 50 milligramme | Not calculated |
| Beta vulgaris Source : Racine Potency : 133.33 milligramme Nitrate | Not specified | Not calculated |
| Withania somnifera Source : Racine Potency : 8 % Withanolides | Not specified | Not calculated |
| Withania somnifera Source : Racine Potency : 32 % Withania oligosaccharides | Not specified | Not calculated |
| Withania somnifera Source : Feuille Potency : 8 % Withanolides | Not specified | Not calculated |
| Withania somnifera Source : Feuille Potency : 32 % Withania oligosaccharides | Not specified | Not calculated |
Non-medicinal ingredients
Hypromellose, Acide citrique, Stéaryl fumarate de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 3 Capsule | 1 day |
Uses authorised in Canada
helps reduce the symptoms of stress, such as fatigue, sleeplessness, irritability, and inability to concentrate. helps reduce cortisol and C-reactive protein level, the biomarkers of physical stress. helps support cardiovascular health. supports nitric oxide level.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a heath care practitioner prior to use if you suffer from cardiovascular disease. Consult a heath care practitioner prior to use if you are taking any prescription medication, such as blood thinners or blood pressure medications. Consult a heath care practitioner prior to use if you are following a diet rich in nitrates (e.g plant from the Amaranthaceae family such as beets, spinach, etc.). consult a health care practitioner prior to use if you are pregnant or breastfeeding. if symptoms persist or worsen, consult a health care practitioner. consumption with alcohol , other drugs or natural health products with sedative properties is not recommended. If you have a liver disorder, consult a health care practitioner prior to use. Stop use if you develop symptoms of liver trouble such as yellowing of the skin/eyes (jaundice), stomach pain, dark urine, sweating, nausea, unusual tiredness and/or loss of appetite and consult a health care practitioner. If you have an iron deficiency, consult a health care practitioner prior to use. If you have high cholesterol, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80087327
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.